Eden Research (LON:EDEN) Trading Down 4.7% – Here’s What Happened

Shares of Eden Research plc (LON:EDEN) fell 4.7% during trading on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). 291,737 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 4.7 %

The firm has a market cap of £18.29 million, a PE ratio of -12.02 and a beta of 0.92. The business has a 50-day moving average price of GBX 3.88 and a two-hundred day moving average price of GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling

In other Eden Research news, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction on Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Also, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). 14.02% of the stock is owned by insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.